Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10322)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Puleo F, Maréchal R, Demetter P, Bali MA, Calomme A, Closset J, Bachet JB, Deviere J, Laethem JLV. New challenges in perioperative management of pancreatic cancer. World J Gastroenterol 2015; 21(8): 2281-2293 [PMID: 25741134 DOI: 10.3748/wjg.v21.i8.2281] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i8/2281.htm |
| Number | Citing Articles |
| 1 |
Rosella Spadi, Federica Brusa, Agostino Ponzetti, Isabella Chiappino, Nadia Birocco, Libero Ciuffreda, Maria Antonietta Satolli. Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. World Journal of Clinical Oncology 2016; 7(1): 27-43 doi: 10.5306/wjco.v7.i1.27
|
| 2 |
Yuan Yu, Lei Liu, Ruirui Ma, Haibing Gong, Ping Xu, Congjun Wang. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer. Tumor Biology 2016; 37(10): 14249 doi: 10.1007/s13277-016-5270-0
|
| 3 |
Stefan Heinrich, Marc Besselink, Markus Moehler, Jean-Luc van Laethem, Michel Ducreux, Peter Grimminger, Jens Mittler, Hauke Lang, Manfred P. Lutz, Mickael Lesurtel. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5889-5
|
| 4 |
Monika Pajewska, Olga Partyka, Aleksandra Czerw, Andrzej Deptała, Elżbieta Cipora, Izabela Gąska, Marek Wojtaszek, Katarzyna Sygit, Marian Sygit, Edyta Krzych-Fałta, Daria Schneider-Matyka, Anna M. Cybulska, Elżbieta Grochans, Alicja Asendrych-Woźniak, Agnieszka Romanowicz, Jarosław Drobnik, Ewa Bandurska, Weronika Ciećko, Barbara Maciuszek-Bartkowska, Mateusz Curyło, Kacper Wróbel, Remigiusz Kozłowski, Michał Marczak. Management of Metastatic Pancreatic Cancer—Comparison of Global Guidelines over the Last 5 Years. Cancers 2023; 15(17): 4400 doi: 10.3390/cancers15174400
|
| 5 |
Ming Li, Dongqiang Xu, Yijun Zhan, Shiyun Tan. IPO7 promotes pancreatic cancer progression via regulating ERBB pathway. Clinics 2022; 77: 100044 doi: 10.1016/j.clinsp.2022.100044
|
| 6 |
Shanshan Huang, Xiong Chen, Jiawei Zheng, Yufang Huang, Li Song, Yin Yin, Jianping Xiong. Low SIRT3 expression contributes to tumor progression, development and poor prognosis in human pancreatic carcinoma. Pathology - Research and Practice 2017; 213(11): 1419 doi: 10.1016/j.prp.2017.07.023
|
| 7 |
Yan Qin Tan, Bowen Sun, Xi Zhang, Shuwei Zhang, Hui Guo, Basappa Basappa, Tao Zhu, Gautam Sethi, Peter E. Lobie, Vijay Pandey. Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma. Cell Death & Disease 2024; 15(2) doi: 10.1038/s41419-024-06551-7
|
| 8 |
Chen-Song Huang, Junjun Chu, Xiao-Xu Zhu, Jian-Hui Li, Xi-Tai Huang, Jian-Peng Cai, Wei Zhao, Xiao-Yu Yin. The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1. Cancer Letters 2018; 421: 63 doi: 10.1016/j.canlet.2018.02.020
|
| 9 |
Liang Xue, Yan Shen, Zhenglong Zhai, Shusen Zheng. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1. International Journal of Molecular Medicine 2020; doi: 10.3892/ijmm.2020.4561
|
| 10 |
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. Cells 2024; 13(7): 602 doi: 10.3390/cells13070602
|
| 11 |
J.W. Gilbert, B. Wolpin, T. Clancy, J. Wang, H. Mamon, A.B. Shinagare, J. Jagannathan, M. Rosenthal. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Annals of Oncology 2017; 28(9): 2067 doi: 10.1093/annonc/mdx180
|
| 12 |
Li-Min Long, Jun-Kun Zhan, Hai-Qin Wang, Shuang Li, Yi-Yin Chen, You-Shuo Liu. The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms. Pathobiology 2017; 84(1): 38 doi: 10.1159/000447302
|
| 13 |
Jayasree Chakraborty, Liana Langdon-Embry, Kristen M. Cunanan, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O’Reilly, Mithat Gönen, Richard G. Do, Amber L. Simpson, Surinder K. Batra. Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. PLOS ONE 2017; 12(12): e0188022 doi: 10.1371/journal.pone.0188022
|
| 14 |
Alessandro Beleù, Angela Calabrese, Giulio Rizzo, Paola Capelli, Nicolò Bellini, Simona Caloggero, Roberto Calbi, Paolo Tinazzi Martini, Riccardo De Robertis, Giovanni Carbognin, Giovanni Marchegiani, Aldo Scarpa, Roberto Salvia, Claudio Bassi, Mirko D’Onofrio. Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study. Cancers 2019; 11(2): 267 doi: 10.3390/cancers11020267
|
| 15 |
Kuldeepsinh P Atodaria, Steven J Cohen, Samyak Dhruv, Shravya R Ginnaram, Shreeja Shah. Trends in Palliative Care, Hospice Utilization, and Outcomes in Hospitalized Pancreatic Cancer Patients: A Nationwide Analysis. Cureus 2022; doi: 10.7759/cureus.29351
|
| 16 |
Yanyan Hu, Chongwei Chi, Shunhao Wang, Lingxiong Wang, Ping Liang, Fangyi Liu, Wenting Shang, Weiwei Wang, Fengrong Zhang, Shanshan Li, Heyun Shen, Xiaoling Yu, Huiyu Liu, Jie Tian. A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic Cancer. Advanced Materials 2017; 29(33) doi: 10.1002/adma.201700448
|
| 17 |
Shanshan Huang, Jiawei Zheng, Yufang Huang, Li Song, Yin Yin, Danzhen Ou, Shangxiang He, Xiong Chen, Xuenong Ouyang. Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/8137378
|
| 18 |
Henu K. Verma, Praveen K. Kampalli, Saikrishna Lakkakula, Gayathri Chalikonda, Lakkakula V.K.S. Bhaskar, Smaranika Pattnaik. A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy. Current Drug Metabolism 2020; 20(12): 958 doi: 10.2174/1389200220666191122104955
|
| 19 |
Marco Cannistrà, Michele Ruggiero, Alessandra Zullo, Simone Serafini, Raffaele Grande, Bruno Nardo. Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept. International Journal of Surgery 2015; 21: S15 doi: 10.1016/j.ijsu.2015.04.093
|
| 20 |
Kenta Shimokawa, Kazumi Wakasugi, Rei Tomonaga, Ken Utsunomiya, Hirotaka Miyamoto, Shintaro Fumoto, Koyo Nishida. Effect of Metabolic Inhibitors on the Hepatic Disposition of 5-Fluorouracil after Application to the Rat Liver Surface. Biological & Pharmaceutical Bulletin 2016; 39(3): 361 doi: 10.1248/bpb.b15-00757
|
| 21 |
Malihe Sadat Razavi, Alyeh Abdollahi, Atefeh Malek-Khatabi, Negin Mousavi Ejarestaghi, Ali Atashi, Nazanin Yousefi, Pedram Ebrahimnejad, Mohamed A. Elsawy, Rassoul Dinarvand. Recent advances in PLGA-based nanofibers as anticancer drug delivery systems. Journal of Drug Delivery Science and Technology 2023; 85: 104587 doi: 10.1016/j.jddst.2023.104587
|
| 22 |
Berta Laquente, Jose Lopez-Martin, Donald Richards, Gerald Illerhaus, David Z. Chang, George Kim, Philip Stella, Dirk Richel, Cezary Szcylik, Stefano Cascinu, G. L. Frassineti, Tudor Ciuleanu, Karla Hurt, Scott Hynes, Ji Lin, Aimee Bence Lin, Daniel Von Hoff, Emiliano Calvo. A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3131-x
|
| 23 |
Yuan Luo, Zhulin Yang, Daiqiang Li, Ziru Liu, Leping Yang, Qiong Zou, Yuan Yuan. LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas. Applied Immunohistochemistry & Molecular Morphology 2017; 25(5): 351 doi: 10.1097/PAI.0000000000000306
|
| 24 |
Victor Lopez-Lopez, Ricardo Robles-Campos, Asunción López-Conesa, Roberto Brusadin, Guillermo Carbonel, Alvaro Gomez-Ruiz, Juan J. Ruiz, Pascual Parrilla. Surgical resection of liver metastasis in pancreatic and periampullary carcinoma. Minerva Chirurgica 2019; 74(3) doi: 10.23736/S0026-4733.18.07972-5
|
| 25 |
Francesco Puleo, Pieter Demetter, Pierre Eisendrath, Raphaël Maréchal, Laurine Verset, Emmanuel Toussaint, Jean-Baptiste Bachet, Marianna Arvanitakis, Ibrahim Mostafa, Jacques Devière, Jean-Luc Van Laethem. Feasibility of Immunohistochemistry on Endoscopic Ultrasound Fine-Needle Aspiration Samples for Evaluating Predictive Biomarkers in Pancreatic Cancer Management. Pancreas 2016; 45(9): e50 doi: 10.1097/MPA.0000000000000672
|
| 26 |
Yuan Feng, Junjun Yang, Wentao Duan, Yu Cai, Xiaohong Liu, Yong Peng. LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1336251
|
| 27 |
Julie Navez, Christelle Bouchart, Diane Lorenzo, Maria Antonietta Bali, Jean Closset, Jean-Luc van Laethem. What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?. Annals of Surgical Oncology 2021; 28(11): 6211 doi: 10.1245/s10434-020-09568-2
|
| 28 |
Mathilde Wagner, Celia Antunes, Daniel Pietrasz, Christophe Cassinotto, Magaly Zappa, Antonio Sa Cunha, Oliver Lucidarme, Jean-Baptiste Bachet. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma. European Radiology 2017; 27(7): 3104 doi: 10.1007/s00330-016-4632-8
|
| 29 |
Olivier Caliez, Daniel Pietrasz, Feryel Ksontini, Solène Doat, Jean-Marc Simon, Jean-Christophe Vaillant, Valerie Taly, Pierre Laurent-Puig, Jean-Baptiste Bachet. Circulating tumor DNA: a help to guide therapeutic strategy in patients with borderline and locally advanced pancreatic adenocarcinoma?. Digestive and Liver Disease 2022; 54(10): 1428 doi: 10.1016/j.dld.2022.01.126
|
| 30 |
Xidong Chen, Haichao Zhao, Changzhou Chen, Jian Li, Jiefeng He, Xifeng Fu, Haoliang Zhao. The HPA/SDC1 axis promotes invasion and metastasis of pancreatic cancer cells by activating EMT via FGF2 upregulation. Oncology Letters 2019; doi: 10.3892/ol.2019.11121
|
| 31 |
Songsong Liu, Junfeng Zhang, Liangyu Yin, Xianxing Wang, Yao Zheng, Yujun Zhang, Jianyou Gu, Ludi Yang, Jiali Yang, Ping Zheng, Yan Jiang, Ling Shuai, Xiongwei Cai, Huaizhi Wang. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Cell Death & Disease 2020; 11(6) doi: 10.1038/s41419-020-2617-7
|
| 32 |
Thomas Seufferlein, Pascal Hammel, Jean Robert Delpero, Teresa Macarulla, Per Pfeiffer, Gerald W. Prager, Michele Reni, Massimo Falconi, Philip A. Philip, Eric Van Cutsem. Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence. Cancer Treatment Reviews 2019; 77: 1 doi: 10.1016/j.ctrv.2019.05.007
|
| 33 |
Pascal Hammel, Cindy Neuzillet, Sihem Bendaoud, Céline Lekhal, Louis de Mestier, Olivia Hentic. Traitement médical du cancer du pancréas : en 10 ans, enfin des progrès. Bulletin du Cancer 2015; 102(6): S62 doi: 10.1016/S0007-4551(15)31219-4
|
| 34 |
Liang Zhao, Hongru Kong, Hongwei Sun, Zongjing Chen, Bicheng Chen, Mengtao Zhou. LncRNA‐PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR‐448. Journal of Cellular Physiology 2018; 233(5): 4044 doi: 10.1002/jcp.26072
|
| 35 |
Thierry Conroy, Jean-Baptiste Bachet, Ahmet Ayav, Florence Huguet, Aurélien Lambert, Caroline Caramella, Raphaël Maréchal, Jean-Luc Van Laethem, Michel Ducreux. Current standards and new innovative approaches for treatment of pancreatic cancer. European Journal of Cancer 2016; 57: 10 doi: 10.1016/j.ejca.2015.12.026
|
| 36 |
Chen Luo, Kang Lin, Cegui Hu, Xiaojian Zhu, Jinfeng Zhu, Zhengming Zhu. LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Molecular Therapy - Nucleic Acids 2021; 26: 523 doi: 10.1016/j.omtn.2021.08.024
|
| 37 |
Daniel Pietrasz, Lysiane Marthey, Mathilde Wagner, Jean-Frédéric Blanc, Christophe Laurent, Olivier Turrini, Jean Luc Raoul, Eric Terrebonne, Olivia Hentic, Isabelle Trouilloud, Romain Coriat, Nicolas Regenet, Pasquale Innominato, Julien Taieb, Antonio Sa Cunha, Jean Baptiste Bachet. Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort. Annals of Surgical Oncology 2015; 22(S3): 1196 doi: 10.1245/s10434-015-4783-x
|
| 38 |
Cheng-Jeng Tai, Hang Wang, Chien-Kai Wang, Chen-Jei Tai, Ming-Te Huang, Chih-Hsiung Wu, Ray-Jade Chen, Li-Jen Kuo, Po-Lei Wei, Yu-Jia Chang, Chun-Chao Chang, Hung-Yi Chiou, Chang-Jer Wu. Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts. Clinical and Experimental Medicine 2017; 17(2): 141 doi: 10.1007/s10238-016-0409-2
|
| 39 |
Liangliang Yang, Zhulin Yang, Daiqiang Li, Ziru Liu, Qiong Zou, Yuan Yuan, Huilan Xu. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma. Pathology & Oncology Research 2018; 24(4): 899 doi: 10.1007/s12253-017-0284-5
|
| 40 |
Hongchao Han, Lisheng Wang, Jie Xu, Aikun Wang. miR‑128 induces pancreas cancer cell apoptosis by targeting MDM4. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6047
|
| 41 |
Gui‑Li Xu, Jian Shen, Yun‑Hua Xu, Wan‑Sheng Wang, Cai‑Fang Ni. ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9500
|
| 42 |
Yu Zhang, Yueying Su, Yabing Zhao, Guoqiang Lv, Ying Luo. MicroRNA-720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1. Molecular Medicine Reports 2017; 16(6): 9256 doi: 10.3892/mmr.2017.7732
|
| 43 |
Yutong Gao, Xiangdi Yu, Fangxiang Zhang, Jing Dai. Propofol inhibits pancreatic cancer progress under hypoxia via ADAM8. Journal of Hepato-Biliary-Pancreatic Sciences 2019; 26(6): 219 doi: 10.1002/jhbp.624
|
| 44 |
Julien Taieb, Gerald W. Prager, Davide Melisi, C. Benedikt Westphalen, Nathalie D'Esquermes, Anabel Ferreras, Alfredo Carrato, Teresa Macarulla. First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study. ESMO Open 2020; 5(1): e000587 doi: 10.1136/esmoopen-2019-000587
|
| 45 |
Sunjong Han, Seong H. Choi, Dong W. Choi, Jin S. Heo, In W. Han, Dae-Joon Park, Youngju Ryu. Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer. Minerva Chirurgica 2020; 75(1) doi: 10.23736/S0026-4733.19.07958-6
|
| 46 |
Bhavik N. Patel, Rajan T. Gupta, Sabino Zani, R. Brooke Jeffrey, Erik K. Paulson, Rendon C. Nelson. How the radiologist can add value in the evaluation of the pre- and post-surgical pancreas. Abdominal Imaging 2015; 40(8): 2932 doi: 10.1007/s00261-015-0549-y
|
| 47 |
Riccardo De Robertis, Paola Capelli, Chiara Longo, Mirko D’Onofrio. Imaging and Pathology of Pancreatic Neoplasms. 2022; : 99 doi: 10.1007/978-3-031-09831-4_2
|
| 48 |
Han-xiang Zhan, Yao Wang, Ce Li, Jian-wei Xu, Bin Zhou, Jian-kang Zhu, Hai-feng Han, Lei Wang, Yun-shan Wang, San-yuan Hu. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway. Cancer Letters 2016; 374(2): 261 doi: 10.1016/j.canlet.2016.02.018
|